In a filing, CME Group Inc. revealed its Director SHEPARD WILLIAM R acquired Company’s shares for reported $0.22 million on Jan 18. In the deal valued at $175.98 per share,1,244 shares were bought. As a result of this transaction, SHEPARD WILLIAM R now holds 249,376 shares worth roughly $ 46.68 million.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Then, SHEPARD WILLIAM R bought 55 shares, generating $9,651 in total proceeds. Upon buying the shares at $175.98, the Director now owns 2,212 shares.
Before that, SHEPARD WILLIAM R bought 289 shares. CME Group Inc. shares valued at $48,645 were divested by the Director at a price of $168.11 per share. As a result of the transaction, SHEPARD WILLIAM R now holds 248,132 shares, worth roughly $46.44 million.
Credit Suisse upgraded its CME Group Inc. [CME] rating to an Outperform from a a Neutral in a research note published on Friday. PT values the company’s stock at a premium of 2.01 to its Friday closing price. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who increased its forecast for the stock in mid October from “a Hold” to “a Buy”. Citigroup began covering CME with “Buy” recommendation on October 12, 2022. Rosenblatt started covering the stock on August 17, 2022. It rated CME as “a Sell”.
Price Performance Review of CME
On Friday, CME Group Inc. [NASDAQ:CME] saw its stock jump 0.04% to $187.17. On the same session, the stock had its day’s lowest price of $185.92, but rose to a high of $187.685. Over the last five days, the stock has lost -0.71%. CME Group Inc. shares have risen nearly 11.30% since the year began. Nevertheless, the stocks have fallen -18.42% over the past one year. While a 52-week high of $245.45 was reached on 02/09/23, a 52-week low of $162.26 was recorded on 01/03/23. SMA at 50 days reached $176.85, while 200 days put it at $187.06. A total of 1.64 million shares were traded, compared to the trading of 1.38 million shares in the previous session.
Levels Of Support And Resistance For CME Stock
The 24-hour chart illustrates a support level at 186.16, which if violated will result in even more drops to 185.16. On the upside, there is a resistance level at 187.93. A further resistance level may holdings at 188.69. The Relative Strength Index (RSI) on the 14-day chart is 65.28, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.86, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 15.18%. Stochastics %K at 84.33% indicates the stock is a selling.
How much short interest is there in CME Group Inc.?
A steep rise in short interest was recorded in CME Group Inc. stocks on Jan 30, 2023, dropping by -0.49 million shares to a total of 3.61 million shares. Yahoo Finance data shows the prior-month short interest on Dec 29, 2022 was 4.1 million shares. There was a decline of -13.57%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 1.01% of the overall stock float, the days-to-cover ratio (short ratio) fell to 1.91.
CME Group Inc. [CME] – Who Are The Largest Shareholders?
In filings from The Vanguard Group, Inc., it is revealed that the company now owns 31,612,280 shares, or roughly 8.79% of the outstanding CME shares. In other words, the investor’s shares have risen by 340,982 from its previous 13-F filing of 31271298.0. Additionally, BlackRock Fund Advisors increased 4.50% of its stake after which the total value it holdings stand at $3,008,963,040, while SSgA Funds Management, Inc. added 1.25% of its stake to hold $2.8 billion in the firm. Over the last quarter, Capital Research & Management Co sold -15,554,066 shares of CME Group Inc., while Capital Research & Management Co sold 27,057 shares. At present, JPMorgan Investment Management, I is holding 9,092,291 shares valued at $1.61 billion. Geode Capital Management LLC owned 6,976,560 shares of the company at the time of its most recent 13F filing, worth $1.23 billion.
According to FactSet, CME Group Inc.’s share price will average $198.67 in the next year, based on opinions of analysts polled by the firm. This is up nearly 7.43 percent from its previous closing price of $187.10. Analysts expect CME Group Inc. stock to reach the higher price of $250.00, while the lowest price estimate is $155.00. However, 19 analysts have rated CME stock as an Overweight in their predictions for 2023.